Yayınlar & Eserler

Yayın Ağı
Makaleler 14
Tümü (14)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (14)
Scopus (14)
TRDizin (1)

1. Phenotypic subgroups and classification criteria performance in paediatric Behçet's disease: insights on systemic involvement

ERCAN EMREOL H., Cam V., SAĞ E., Bayindir Y., Unal D., Erkan M. O., et al.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) identifier

2. Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study

Cam V., Unal D., SAĞ E., Bayindir Y., Aliyev E., Emreol H., et al.
RHEUMATOLOGY , cilt.64, sa.11, ss.5726-5732, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

3. Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort

Unal D., Yigit Y. D., BAŞARAN H. Ö., YILDIZ A. E., Bayindir Y., Cam V., et al.
CLINICAL RHEUMATOLOGY , cilt.44, sa.10, ss.4229-4236, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

4. Validation of Axial Juvenile Spondyloarthropathy Criteria in Turkish Juvenile Spondyloarthropathy Patients

Unal D., Tatar C. A., SAĞ E., Bayindir Y., Aliyev E., Cam V., et al.
DIAGNOSTICS , cilt.15, sa.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

5. A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin

ÇAM V., SAĞ E., BİLGİNER Y., ÖZEN S.
RHEUMATOLOGY , sa.4, ss.2315-2316, 2025 (SCI-Expanded, Scopus) identifier identifier

6. Long-term follow-up after discontinuation of anti-IL1 treatment in colchicine-resistant familial Mediterranean fever

ÇAM V., BAYINDIR Y., BİLGİNER Y., ÖZEN S.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

7. A challenging case of limb autoamputation

Aliyev E., CELEP İ., ÇAM V., ÖZEN S., SAĞ E.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

8. New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases

ÇAM V., Emreol H., ÖZEN S.
ARCHIVES OF RHEUMATOLOGY , cilt.39, sa.3, ss.331-338, 2024 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

9. Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update

ÜNAL D., ÇAM V., Emreol H., ÖZEN S.
PEDIATRIC DRUGS , cilt.26, sa.4, ss.381-395, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.
Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

11. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.
Clinical Rheumatology , cilt.43, sa.2, ss.591-602, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

12. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?

BATU AKAL E. D., ŞENER S., BALIK Z., BAYINDIR Y., ÇAM V., KASAP CÜCEOĞLU M., et al.
Clinical Rheumatology , cilt.43, sa.1, ss.415-421, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

13. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

ŞENER S., ÇAM V., BATU AKAL E. D., KASAP CÜCEOĞLU M., BALIK Z., Aliyev E., et al.
Rheumatology (Oxford, England) , cilt.62, sa.11, ss.3700-3705, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

14. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data

BATU AKAL E. D., ŞENER S., ÇAM V., Aktay Ayaz N., ÖZEN S.
BioDrugs , cilt.37, sa.6, ss.813-828, 2023 (SCI-Expanded, Scopus) identifier identifier identifier